XTL BIOPHARMACEUTICALS LTD. Increase Decrease In Deferred Tax Liability Asset
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Increase Decrease In Deferred Tax Liability Asset of $101.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Notes › Income Taxes
ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset · last filed 2025-04-30
| Period end | Increase Decrease In Deferred Tax Liability Asset 12 month |
|---|---|
| 2024-12-31 | $101.00K 20-F · filed 2025-04-30 |
| 2023-12-31 | $141.00K 20-F · filed 2025-04-30 |
| 2022-12-31 | $86.00K 20-F · filed 2023-03-22 |
| 2021-12-31 | $400.00K 20-F · filed 2023-03-22 |